Navigation Links
Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference
Date:11/12/2007

FULLERTON, Calif., Nov. 12 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that Charles Slacik, Beckman Coulter's senior vice president and chief financial officer, will present at the 2007 Credit Suisse Global Healthcare Conference on Thursday, November 15, 2007, at 11:00 a.m. (ET).

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

The live webcast of Beckman Coulter's presentation can be accessed by visiting their website at http://www.beckmancoulter.com. To access the webcast select "go to IR" under Investor Relations and find the event listed under "What's Ahead." The webcast will be archived on the company's website for future on-demand replay through December 7, 2007.

Beckman Coulter, Inc., based in Fullerton, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represent more than 75 percent of the company's 2006 revenue of $2.53 billion. For more information, visit http://www.beckmancoulter.com.

Contact: Cynthia Skoglund (714) 773-8213

Manager, Investor Relation
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
2. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
3. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
4. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
5. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
6. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
7. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
8. AtriCure to Present at Roth Capital Partners 2007 New York Conference
9. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
10. MDS to Present at Thomas Weisel Partners Healthcare Conference
11. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...a statement of concern issued by a senior health o...ing the financial and human resources // needed ...roblem is more severe in southern and western regi...l it," Mr Wu a top Aids official at the Chinese Ce...
...ombination of radiation and gold nanoparticles can...disease, according to a research conducted by scie.../ cells will not be affected by this. According t...emical Society's Nano Letters, the technique, a ty...
...ts pharmacies have handed out over 6,000 chlamydia...a pilot scheme aimed at tackling the silent sex di...Screening Program which last year revealed as many... have the disease. The trial was launched in Novem...
...S strategies designed to detect and contain the sp...ch more needs to be done than mere rhetoric // on...from spreading beyond the recognized risk groups o...ere that testing for AIDS assumes massive importan...
Other Medicine News:Health News:Need of the Hour: Viable Strategies against AIDS 2
(Date:9/4/2008)... MELBOURNE, Australia, Sept. 4 /- C...is commencing enrolment for its Phase Ib/II,study ... anticancer agent,in patients with an aggressive ...rme (GBM)., The GBM clinical trial is the first P...umor indications for the company and the second in...
(Date:9/4/2008)... Practice Bulletin for Obstetrician-Gynecologist...ractice Change-Minimally Invasive Interventional,R...omen With Uterine,Fibroids, FAIRFAX, Va., Sept. 4...ntional Radiology, a national organization of near...fessionals dedicated to improving health,care thro...
(Date:9/4/2008)... 100 mg cohort demonstrates potent antiviral activ... profile -, CAMBRIDGE, Mass., Sept. 4 /PRNews...asdaq: IDIX ), a biopharmaceutical company engage...e treatment of human viral,and other infectious di...proof-of-concept study evaluating IDX899, a non-nu...
(Date:9/3/2008)... NANJING, China, Sept. 3 /PRNewswire-FirstCall/ ...eading manufacturer and supplier of,branded generi...,anti-cancer biotech product Endu (also known as E...f Endu Phase IV clinical study., At the request o...study,to further validate the safety and therapeut...
Breaking Medicine Technology:Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Pelosi Statement on House Passage of Global AIDS Legislation 24381 1Pelosi Statement on House Passage of Global AIDS Legislation 24381 2NuVasive Completes Acquisition of Osteocel Biologics Business 6732 1NuVasive Completes Acquisition of Osteocel Biologics Business 6732 2NuVasive Completes Acquisition of Osteocel Biologics Business 6732 3NuVasive Completes Acquisition of Osteocel Biologics Business 6732 4NuVasive Completes Acquisition of Osteocel Biologics Business 6732 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 1Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 8Rochester Medical Announces Third Quarter 2008 Earnings Conference Call July 31 2008 6727 1Rochester Medical Announces Third Quarter 2008 Earnings Conference Call July 31 2008 6727 2
Clearview C. Diff A is a one-step test for the direct qualitative detection of Clostridium difficile toxin A from fecal samples.
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults.
...est is one of the easiest tests to run on the mark...s with no hands-on time. Critical care instruction...aving the pediatrician's office and valuable infor... to help control the spread of RSV infections. Now...
The BinaxNOW Influenza A & B Test simplifies rapid influenza testing. The easiest flu test on the market just got easier with accurate differentiation between influenza A and influenza B using one si
Medicine Products: